US pharmaceutical company buys Pharmasset in a cash deal intended to capitalise on growing demand for oral hepatitis C medicine Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,